Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Epithelial Ovarian Cancer

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Epithelial Ovarian Cancer in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Although ovarian cancer and breast cancer have comparable levels of HER2/ErbB2 expression, clinical studies of pertuzumab in epithelial ovarian cancer patients have not met the same level of success."1.42miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation. ( Li, Y; Ma, C; Wang, J; Wuerkenbieke, D, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wuerkenbieke, D1
Wang, J1
Li, Y1
Ma, C1
Xu, CL1
Lu, XL1
Yan, XN1
Wang, HL1
Chen, SQ1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Epithelial Ovarian Cancer

ArticleYear
miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.
    Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Ov

2015
[Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Zhonghua fu chan ke za zhi, 2012, Volume: 47, Issue:2

    Topics: Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Chromones; E

2012